Overview

GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

Status:
Completed
Trial end date:
2018-04-09
Target enrollment:
Participant gender:
Summary
To investigate the potential antiepileptic effects of cannabidiol (GWP42003-P) in children and young adults with Dravet syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
GW Research Ltd
Treatments:
Cannabidiol